|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
5 events,
This online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications. Learning Objectives For […]
Free
Breast cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death in women worldwide. Despite significant advancements in imaging and treatment, clinical practice remains heterogeneous across institutions and disciplines. Molecular imaging has a pivotal role in breast cancer care, from diagnosis to recurrence assessment. To address these discrepancies and define the […]
Free
This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting […]
Free
New ESMIT Learning format: Self-paced online course followed by a live session with the course faculty, where participants are able to ask their questions live!* Nuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of […]
Free
This course will be published in February 2026. Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and beyond. The online course will cover the spectrum of radiolabelled PSMA tracers, techniques related […]
Free
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
6 events,
-
More info will come soon Learning Objectives Target Audience Faculty Event Overview |
5 events,
|
5 events,
|
|
5 events,
|
5 events,
|
5 events,
|
6 events,
This intensive 1,5-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response relationships in the three most commonly used theranostic molecules: somatostatin-ligands for neuroendocrine tumours, PSMA-inhibitors for prostate cancer, and radioiodine for thyroid malignancies. Through a balanced […]
€950
|
6 events,
|
5 events,
|
5 events,
|
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
6 events,
-
More info will come soon Learning Objectives Target Audience Faculty Event Overview |
5 events,
|
5 events,
|
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
5 events,
|
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
